$ASTH
Astrana Health, Inc.

2012 Form 10-K Financial Statement

#000114420412029578 Filed on May 15, 2012

View on sec.gov

Income Statement

Concept 2012 2011 Q1 2011
Revenue $5.111M $1.000M $3.897M
YoY Change 31.16% 42.86% -0.09%
Cost Of Revenue $4.132M $900.0K $3.315M
YoY Change 24.67% 50.0% 0.45%
Gross Profit $978.4K $100.0K $581.9K
YoY Change 68.15% -50.0% -3.02%
Gross Profit Margin 19.14% 10.0% 14.93%
Selling, General & Admin $3.500M $100.0K $1.400M
YoY Change 150.0% -66.67% 133.33%
% of Gross Profit 357.72% 100.0% 240.61%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $12.59K $0.00 $11.20K
YoY Change 12.42% -100.0% 11.98%
% of Gross Profit 1.29% 0.0% 1.92%
Operating Expenses $1.392M $100.0K $577.8K
YoY Change 140.85% -50.0% -3.69%
Operating Profit -$413.3K $0.00 $4.015K
YoY Change -10394.77% -3448858738688100.0%
Interest Expense $131.5K $0.00 $126.4K
YoY Change 4.04% -226.43%
% of Operating Profit 0.0% 3148.97%
Other Income/Expense, Net -$301.2K $0.00 $158.7K
YoY Change -289.73%
Pretax Income -$714.5K -$100.0K -$154.7K
YoY Change 361.79% 0.0% -22.63%
Income Tax $5.819K $0.00 $1.600K
% Of Pretax Income
Net Earnings -$720.3K -$100.0K -$156.3K
YoY Change 360.78% 0.0% -21.83%
Net Earnings / Revenue -14.09% -10.0% -4.01%
Basic Earnings Per Share
Diluted Earnings Per Share -$2.781M -$35.71K -$241.4K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2012 2011 Q1 2011
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.200M $400.0K $200.0K
YoY Change 500.0% -42.86% -50.0%
Cash & Equivalents $1.200M $397.1K $200.0K
Short-Term Investments
Other Short-Term Assets $100.0K $0.00 $0.00
YoY Change
Inventory
Prepaid Expenses $29.14K
Receivables $1.600M $705.0K $1.000M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $2.900M $1.197M $1.200M
YoY Change 141.67% -0.21% 0.0%
LONG-TERM ASSETS
Property, Plant & Equipment $100.0K $21.59K $0.00
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $200.0K $0.00 $0.00
YoY Change -100.0%
Total Long-Term Assets $300.0K $60.66K $200.0K
YoY Change 50.0% -39.34% 100.0%
TOTAL ASSETS
Total Short-Term Assets $2.900M $1.197M $1.200M
Total Long-Term Assets $300.0K $60.66K $200.0K
Total Assets $3.200M $1.258M $1.400M
YoY Change 128.57% -3.22% 7.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $400.0K $0.00 $100.0K
YoY Change 300.0%
Accrued Expenses $600.0K $0.00 $0.00
YoY Change -100.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $600.0K $0.00 $600.0K
YoY Change 0.0%
Total Short-Term Liabilities $1.700M $92.75K $1.500M
YoY Change 13.33% -7.26% 1400.0%
LONG-TERM LIABILITIES
Long-Term Debt $1.900M $1.200M $200.0K
YoY Change 850.0% 0.0% -83.33%
Other Long-Term Liabilities $0.00 $0.00 $100.0K
YoY Change -100.0%
Total Long-Term Liabilities $1.900M $1.200M $300.0K
YoY Change 533.33% 0.0% -75.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.700M $92.75K $1.500M
Total Long-Term Liabilities $1.900M $1.200M $300.0K
Total Liabilities $3.600M $1.341M $2.000M
YoY Change 80.0% -16.17% 25.0%
SHAREHOLDERS EQUITY
Retained Earnings -$1.397M
YoY Change
Common Stock $27.64K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$400.0K -$311.3K -$700.0K
YoY Change
Total Liabilities & Shareholders Equity $3.200M $1.258M $1.400M
YoY Change 128.57% -3.22% 7.69%

Cashflow Statement

Concept 2012 2011 Q1 2011
OPERATING ACTIVITIES
Net Income -$720.3K -$100.0K -$156.3K
YoY Change 360.78% 0.0% -21.83%
Depreciation, Depletion And Amortization $12.59K $0.00 $11.20K
YoY Change 12.42% -100.0% 11.98%
Cash From Operating Activities -$385.5K -$90.00K -$245.0K
YoY Change 57.31% -40.0% -1.99%
INVESTING ACTIVITIES
Capital Expenditures $7.205K -$20.00K $21.17K
YoY Change -65.96% -205.83%
Acquisitions
YoY Change
Other Investing Activities $10.00K $0.00 $160.0K
YoY Change -93.75%
Cash From Investing Activities $157.0K -$10.00K -$21.17K
YoY Change -841.81% 5.83%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -4.290K 0.000 -2.440K
YoY Change 75.82% -100.0%
NET CHANGE
Cash From Operating Activities -385.5K -90.00K -245.0K
Cash From Investing Activities 157.0K -10.00K -21.17K
Cash From Financing Activities -4.290K 0.000 -2.440K
Net Change In Cash -232.7K -100.0K -268.6K
YoY Change -13.36% -50.0% -0.51%
FREE CASH FLOW
Cash From Operating Activities -$385.5K -$90.00K -$245.0K
Capital Expenditures $7.205K -$20.00K $21.17K
Free Cash Flow -$392.7K -$70.00K -$266.2K
YoY Change 47.51% -53.33% 15.74%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2011Q1 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
37500
CY2011Q1 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
39500
CY2011Q1 us-gaap Liabilities Current
LiabilitiesCurrent
92745
CY2012Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
30635774 shares
CY2011Q3 dei Entity Public Float
EntityPublicFloat
988413
CY2010Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
665737
CY2010Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-46393
CY2011Q1 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
1248588
CY2011Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1397363
CY2011Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
704971
CY2011Q1 us-gaap Assets
Assets
1258139
CY2011Q1 us-gaap Common Stock Value
CommonStockValue
27636
CY2011Q1 us-gaap Minority Interest
MinorityInterest
228115
CY2011Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27635774 shares
CY2011Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2011Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2011Q1 us-gaap Liabilities
Liabilities
1341333
CY2011Q1 us-gaap Assets Current
AssetsCurrent
1197483
CY2011Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
29138
CY2011Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
397101
CY2011Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2011Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1058418
CY2011Q1 us-gaap Due From Officers Or Stockholders Current
DueFromOfficersOrStockholdersCurrent
24873
CY2011Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
92745
CY2011Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1258139
CY2011Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2011Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2011Q1 us-gaap Stockholders Equity
StockholdersEquity
-311309
CY2011Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27635774 shares
CY2011Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2011Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21593
CY2011Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-83194
CY2011Q1 us-gaap Due From Affiliate Current
DueFromAffiliateCurrent
3900
CY2012Q1 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
37500
CY2012Q1 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
1563
CY2012Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1515268
CY2012Q1 us-gaap Advances On Inventory Purchases
AdvancesOnInventoryPurchases
2140
CY2012Q1 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
150000
CY2012Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
653026
CY2012Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2117708
CY2012Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
994118
CY2012Q1 us-gaap Assets
Assets
1364048
CY2012Q1 us-gaap Common Stock Value
CommonStockValue
29336
CY2012Q1 us-gaap Minority Interest
MinorityInterest
238101
CY2012Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
90000
CY2012Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29335774 shares
CY2012Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2012Q1 us-gaap Assets Current
AssetsCurrent
1249224
CY2012Q1 us-gaap Goodwill
Goodwill
32000
CY2012Q1 us-gaap Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
12400
CY2012Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
45601
CY2012Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
164361
CY2012Q1 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
120000
CY2012Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
596366
CY2012Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1429051
CY2012Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
163476
CY2012Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1364048
CY2012Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2012Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2012Q1 us-gaap Stockholders Equity
StockholdersEquity
-659321
CY2012Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
29335774 shares
CY2012Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
38000
CY2012Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2012Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
43261
CY2012Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2012Q1 us-gaap Liabilities
Liabilities
1785268
CY2012Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-421220
CY2012Q1 us-gaap Due From Affiliate Current
DueFromAffiliateCurrent
5504
CY2012Q1 ameh Convertible Notes Current Unamortized Discount
ConvertibleNotesCurrentUnamortizedDiscount
653026
CY2011 us-gaap Gross Profit
GrossProfit
581862
CY2011 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
72152
CY2011 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-21165
CY2011 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
290363
CY2011 us-gaap Income Taxes Paid
IncomeTaxesPaid
1600
CY2011 us-gaap Revenues
Revenues
3896584
CY2011 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-245031
CY2011 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1006
CY2011 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
47378
CY2011 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-154731
CY2011 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-1027
CY2011 us-gaap Depreciation
Depreciation
11198
CY2011 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-11507
CY2011 us-gaap Interest Expense
InterestExpense
126431
CY2011 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
42908
CY2011 us-gaap Net Income Loss
NetIncomeLoss
-156331
CY2011 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
158746
CY2011 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
72152
CY2011 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
21165
CY2011 us-gaap Operating Income Loss
OperatingIncomeLoss
4015
CY2011 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
5185
CY2011 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1600
CY2011 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-268636
CY2011 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
2440
CY2011 us-gaap Interest Paid
InterestPaid
125425
CY2011 us-gaap Operating Expenses
OperatingExpenses
577847
CY2011 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
566649
CY2011 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2440
CY2011 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
37500
CY2011 us-gaap Cost Of Services
CostOfServices
3314722
CY2011 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-37500
CY2011 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2011 ameh Weighted Average Number Basic Diluted Shares Outstanding
WeightedAverageNumberBasicDilutedSharesOutstanding
27490476 shares
CY2012 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2012 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2012 dei Trading Symbol
TradingSymbol
AMEH
CY2012 dei Entity Registrant Name
EntityRegistrantName
APOLLO MEDICAL HOLDINGS, INC.
CY2012 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2012 dei Amendment Flag
AmendmentFlag
false
CY2012 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2012 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2012
CY2012 dei Document Type
DocumentType
10-K
CY2012 dei Document Period End Date
DocumentPeriodEndDate
2012-01-31
CY2012 dei Entity Central Index Key
EntityCentralIndexKey
0001083446
CY2012 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2012 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-31
CY2012 us-gaap Gross Profit
GrossProfit
978407
CY2012 us-gaap Stock Issued1
StockIssued1
280000
CY2012 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
150000
CY2012 us-gaap Increase Decrease In Due From Officers And Stockholders Current
IncreaseDecreaseInDueFromOfficersAndStockholdersCurrent
-14953
CY2012 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
157005
CY2012 us-gaap Minority Interest Period Increase Decrease
MinorityInterestPeriodIncreaseDecrease
-154290
CY2012 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
407224
CY2012 us-gaap Income Taxes Paid
IncomeTaxesPaid
2400
CY2012 us-gaap Revenues
Revenues
5110806
CY2012 us-gaap Increase Decrease Due From Affiliates
IncreaseDecreaseDueFromAffiliates
1604
CY2012 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-385455
CY2012 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
804
CY2012 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
152400
CY2012 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-714527
CY2012 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
22668
CY2012 us-gaap Depreciation
Depreciation
12589
CY2012 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
154290
CY2012 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
70731
CY2012 us-gaap Minority Interest Increase From Stock Issuance
MinorityInterestIncreaseFromStockIssuance
164276
CY2012 us-gaap Interest Expense
InterestExpense
131534
CY2012 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
118077
CY2012 us-gaap Net Income Loss
NetIncomeLoss
-720346
CY2012 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-301192
CY2012 us-gaap Asset Impairment Charges
AssetImpairmentCharges
210000
CY2012 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
29333
CY2012 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7205
CY2012 us-gaap Nature Of Operations
NatureOfOperations
<div style="FONT: 10pt Times New Roman, Times, Serif"> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"><b>1. Organization and Summary of Critical Accounting Policies</b></p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#xA0;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">Apollo Medical Holdings, Inc. (&#x201C;Apollo&#x201D; or the &#x201C;Company&#x201D;) is a leading provider of hospitalist services in the Greater Los Angeles, California area. Hospitalist medicine is organized around the admission and care of patients in an inpatient facility such as a hospital or skilled nursing facility and is focused on providing, managing and coordinating the care of hospitalized patients. Apollo Medical Holdings, Inc. operates as a medical management holding company that focuses on managing the provision of hospital-based medicine through a wholly owned subsidiary-management companies, Apollo Medical Management, Inc. (&#x201C;AMM&#x201D;) and Pulmonary Critical Care Management, Inc. (&#x201C;PCCM&#x201D;). Through AMM and PCCM, the Company manages affiliated medical groups, which primarily consists of ApolloMed Hospitalists (&#x201C;AMH and Los Angeles Lung Center (&#x201C;LALC&#x201D;). AMM and PCCM operate as a Physician Practice Management Company (PPM) and is in the business of providing management services to Physician Practice Companies (PPC) under Management Service Agreements.</p> </div>
CY2012 us-gaap Operating Income Loss
OperatingIncomeLoss
-413335
CY2012 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
2842
CY2012 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5819
CY2012 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-232740
CY2012 us-gaap Interest Paid
InterestPaid
129000
CY2012 us-gaap Operating Expenses
OperatingExpenses
1391742
CY2012 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
63000
CY2012 us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
120000
CY2012 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1379153
CY2012 us-gaap Proceeds From Divestiture Of Interest In Consolidated Subsidiaries
ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries
164210
CY2012 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4290
CY2012 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
172500
CY2012 us-gaap Cost Of Services
CostOfServices
4132399
CY2012 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-37500
CY2012 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2012 ameh Compensation Expense Related Stock Options
CompensationExpenseRelatedStockOptions
29333
CY2012 ameh Weighted Average Number Basic Diluted Shares Outstanding
WeightedAverageNumberBasicDilutedSharesOutstanding
29078925 shares
CY2012 ameh Issuance Of Common Stock Value For Stock Based Compensation
IssuanceOfCommonStockValueForStockBasedCompensation
90000

Files In Submission

Name View Source Status
0001144204-12-029578-index-headers.html Edgar Link pending
0001144204-12-029578-index.html Edgar Link pending
0001144204-12-029578.txt Edgar Link pending
0001144204-12-029578-xbrl.zip Edgar Link pending
ameh-20120131.xml Edgar Link completed
ameh-20120131.xsd Edgar Link pending
ameh-20120131_cal.xml Edgar Link unprocessable
ameh-20120131_def.xml Edgar Link unprocessable
ameh-20120131_lab.xml Edgar Link unprocessable
ameh-20120131_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v312954_10k.htm Edgar Link pending
v312954_ex21-1.htm Edgar Link pending
v312954_ex31-1.htm Edgar Link pending
v312954_ex31-2.htm Edgar Link pending
v312954_ex32-1.htm Edgar Link pending
v312954_ex32-2.htm Edgar Link pending